treatment of spm with egta , to minimize the presence of bound cytoplasmic activator calmodulin , resulted in a mixed mechanism of inhibition of the enzyme activity ( vmax was decreased and km increased ) as estimated by lineweaver-burk plots .
C0007603
spm
C0010834
cytoplasmic